MMG Introduces Enhanced Education Platform for Clinical Trials
MMG announced an exclusive strategic partnership with online healthcare communications company MedRespond to introduce Custom Conversations
MMG, a global health communications company specializing in clinical trial patient recruitment and retention, announced an exclusive strategic partnership with online healthcare communications company MedRespond to introduce Custom Conversations, its new technological advancement in clinical trial patient education.
Custom Conversations uses video, natural language query capabilities, and the Internet to allow people exploring clinical trial options to have a more customized online learning interaction. An advanced synthetic interview technology developed by Carnegie Mellon University, allows people to also can ask questions in their own words, and then receive pre-recorded video responses which have been pre-approved by the study’s institutional review board or ethics committee.
According to MMG, pilot programs have shown clear boosts in enrollment rates compared to trials for which patients received only traditional study educational materials.
The Custom Conversations platform can be also be leveraged throughout the study education continuum – from first learning about a study, to pre-qualification and screening, and for the duration of the study, which can help to fortify retention. Sponsors receive insight into the anonymous activity data to get a view into patients’ and caregivers’ communication needs and mindsets, which can be used to refine recruitment and retention strategies and messaging.
Read the full release here.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
